Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Luxfer Holdings PLCNYSE: LXFR
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables turns positive
Q1 FY2026 accounts payables was $3.2M, compared with -$4.4M a year earlier. Trailing-twelve-month accounts payables was $2.04M.
Context
- Accounts payables amounted to 1.5% of revenue in FY2025, up 0.3 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near $3.2M or moves back toward the trailing-twelve-month quarterly average of $509.39K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (5.7M) USD
- Year-over-year change
- -218.8%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5.7M) | -218.8% |
| FY2024 | 2024-12-31 | 4.8M | +125.3% |
| FY2023 | 2023-12-31 | (19M) | -189.2% |
| FY2022 | 2022-12-31 | 21.3M | +86.8% |
| FY2021 | 2021-12-31 | 11.4M | — |
Accounts Payables vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 accounts payables of $2.04M is the 7th largest of the 11 companies compared; the peer median is $1.07M.
- Its year-over-year change of +138.4% is the 3rd highest of 10, against a peer median of -72.8%.
- Accounts payables amounts to 0.5% of revenue for LXFR, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $64.2M | — | — | 4.4% | |
| LTM Mar 2026 | $37.92M | -228.6% | — | 5.7% | |
| LTM Mar 2026 | $27.64M | +183.0% | — | 4.1% | |
| LTM Mar 2026 | $9.07M | +64.2% | -8.2% | 2.1% | |
| LTM Mar 2026 | $4.2M | -151.2% | — | 0.3% | |
| LTM Mar 2026 | $2.33M | +10.1% | +157.0% | 0.6% | |
| LTM Mar 2026 | $2.04M | +138.4% | — | 0.5% | |
| LTM Mar 2026 | $1.6M | -115.0% | — | 0.1% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $1.36M | -74.3% | +149.1% | 0.8% |
| LTM Mar 2026 | $774K | +215.7% | -47.7% | 0.8% | |
| LTM Mar 2026 | $503K | -72.8% | +13.3% | — | |
| Peer median (excluding LXFR) | $1.07M | -72.8% | +13.3% | 0.8% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 30M | 32M | (2.6M) | 18.3M | 7.7M |
| Depreciation & Amortization | 15.6M | 18M | 12.7M | 13.4M | 9.9M |
| Deferred Income Tax | (1.6M) | 8.7M | (600K) | 1.1M | 6.2M |
| Stock-Based Compensation | 2.8M | 2.5M | 2.8M | 3.5M | 3.6M |
| Change in Working Capital | (1.2M) | (46.6M) | (8M) | 8.9M | (8.9M) |
| Accounts Receivables | (9.8M) | (25.3M) | 16.6M | (4.3M) | 4.3M |
| Inventory | (15.3M) | (25M) | 16.6M | (4.1M) | (6.7M) |
| Accounts Payables | 11.4M | 21.3M | (19M) | 4.8M | (5.7M) |
| Other Working Capital | 12.5M | (17.6M) | (22.2M) | 12.5M | (800K) |
| Other Non-Cash Items | (19.5M) | 1.3M | 22M | 5.9M | 15.5M |
| Operating Cash Flow | 26.1M | 15.9M | 26.3M | 51.1M | 34M |
| Capital Expenditures | (9.1M) | (8.3M) | (9.4M) | (10.3M) | (7.8M) |
| Acquisitions (Net) | 4.1M | (1M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | 3.6M | (100K) | 7.3M | 2.7M |
| Investing Cash Flow | (5.1M) | (5.7M) | (9.5M) | (3.4M) | (5.1M) |
| Debt Repayment | 6.4M | 24.8M | (10.2M) | (27.2M) | (7.2M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (6.4M) | (11.1M) | (2.7M) | (2.3M) | (3.1M) |
| Dividends Paid | (13.6M) | (14.2M) | (14M) | (14M) | (13.9M) |
| Other Financing Activities | (2.5M) | (1.4M) | (600K) | (500K) | (800K) |
| Financing Cash Flow | (16.1M) | (2M) | (27.5M) | (44M) | (25M) |
| Effect of Forex Changes | 0 | (1.7M) | 400K | 0 | 500K |
| Net Change in Cash | 4.9M | 6.5M | (10.3M) | 3.7M | 4.4M |
| Free Cash Flow | 17M | 7.6M | 16.9M | 40.8M | 26.2M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.